i-SENS Inc (099190) - Cash Flow Conversion Efficiency
Based on the latest financial reports, i-SENS Inc (099190) has a cash flow conversion efficiency ratio of -0.004x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-1.56 Billion ≈ $-1.06 Million USD) by net assets (₩356.49 Billion ≈ $241.59 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of i-SENS Inc for the company's overall valuation and market capitalisation.
i-SENS Inc - Cash Flow Conversion Efficiency Trend (2012–2025)
This chart illustrates how i-SENS Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
i-SENS Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of i-SENS Inc ranked by their cash flow conversion efficiency. Explore i-SENS Inc cash flow quality index to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
T&L Co. Ltd
KQ:340570
|
0.049x |
|
Mycenax Biotech
TWO:4726
|
-0.031x |
|
Alicanto Minerals Ltd
AU:AQI
|
-0.078x |
|
Paxman AB
ST:PAX
|
-0.014x |
|
Hope Education Group Co. Ltd
F:HE1
|
0.049x |
|
Wanhwa Enterprise Co
TW:2701
|
0.006x |
|
Seoul City Gas
KO:017390
|
-0.022x |
|
Southern Petrochemicals Industries Corporation Limited
NSE:SPIC
|
0.592x |
Annual Cash Flow Conversion Efficiency for i-SENS Inc (2012–2025)
The table below shows the annual cash flow conversion efficiency of i-SENS Inc from 2012 to 2025. View i-SENS Inc stock quote for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩338.32 Billion ≈ $229.28 Million |
₩20.12 Billion ≈ $13.63 Million |
0.059x | -11.16% |
| 2024-12-31 | ₩342.98 Billion ≈ $232.43 Million |
₩22.96 Billion ≈ $15.56 Million |
0.067x | +55.73% |
| 2023-12-31 | ₩303.49 Billion ≈ $205.67 Million |
₩13.05 Billion ≈ $8.84 Million |
0.043x | +84.64% |
| 2022-12-31 | ₩285.81 Billion ≈ $193.69 Million |
₩6.65 Billion ≈ $4.51 Million |
0.023x | -63.73% |
| 2021-12-31 | ₩268.33 Billion ≈ $181.84 Million |
₩17.22 Billion ≈ $11.67 Million |
0.064x | -59.30% |
| 2020-12-31 | ₩219.49 Billion ≈ $148.75 Million |
₩34.61 Billion ≈ $23.46 Million |
0.158x | -17.49% |
| 2019-12-31 | ₩198.56 Billion ≈ $134.56 Million |
₩37.95 Billion ≈ $25.72 Million |
0.191x | +76.94% |
| 2018-12-31 | ₩180.93 Billion ≈ $122.61 Million |
₩19.54 Billion ≈ $13.24 Million |
0.108x | -21.41% |
| 2017-12-31 | ₩162.80 Billion ≈ $110.32 Million |
₩22.38 Billion ≈ $15.16 Million |
0.137x | +75.44% |
| 2016-12-31 | ₩149.67 Billion ≈ $101.43 Million |
₩11.73 Billion ≈ $7.95 Million |
0.078x | -54.15% |
| 2015-12-31 | ₩132.02 Billion ≈ $89.47 Million |
₩22.56 Billion ≈ $15.29 Million |
0.171x | +13.76% |
| 2014-12-31 | ₩118.81 Billion ≈ $80.51 Million |
₩17.85 Billion ≈ $12.09 Million |
0.150x | -3.22% |
| 2013-12-31 | ₩104.32 Billion ≈ $70.70 Million |
₩16.19 Billion ≈ $10.97 Million |
0.155x | +108.16% |
| 2012-12-31 | ₩68.44 Billion ≈ $46.38 Million |
₩5.10 Billion ≈ $3.46 Million |
0.075x | -- |
About i-SENS Inc
i-SENS, Inc. provides diagnostic biosensors in South Korea. The company offers point of care testing devices, such as HbA1c, blood gas, electrolyte, and PT/INR analyzers; CareSens blood glucose monitoring systems; and lancing and other ancillary devices, as well as diabetes management services. It exports its products to approximately 110 countries, including the United States, Japan, and Europe.… Read more